332 related articles for article (PubMed ID: 7585526)
1. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
3. Pituitary lactotrope expresses transforming growth factor beta (TGF beta) type II receptor mRNA and protein and contains 125I-TGF beta 1 binding sites.
De A; Morgan TE; Speth RC; Boyadjieva N; Sarkar DK
J Endocrinol; 1996 Apr; 149(1):19-27. PubMed ID: 8676051
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth.
Sarkar DK; Kim KH; Minami S
Mol Endocrinol; 1992 Nov; 6(11):1825-33. PubMed ID: 1480172
[TBL] [Abstract][Full Text] [Related]
5. Ethanol induces hyperprolactinemia by increasing prolactin release and lactotrope growth in female rats.
De A; Boyadjieva N; Oomizu S; Sarkar DK
Alcohol Clin Exp Res; 2002 Sep; 26(9):1420-9. PubMed ID: 12351938
[TBL] [Abstract][Full Text] [Related]
6. [Effects of growth factors and estrogen on the proliferation and prolactin gene expression in anterior pituitary cells of rats].
Wu X; Zhang R; Di A; Shan H; Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):331-7. PubMed ID: 12567429
[TBL] [Abstract][Full Text] [Related]
7. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of TGF-beta 1 gene expression in anterior pituitary cells treated with forskolin.
Pastorcic M; Sarkar DK
Cytokine; 1997 Feb; 9(2):106-11. PubMed ID: 9071561
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
Braun L; Gruppuso P; Mikumo R; Fausto N
Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
[TBL] [Abstract][Full Text] [Related]
11. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells.
Lee EH; Joo CK
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
13. Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.
Sarkar DK; Chaturvedi K; Oomizu S; Boyadjieva NI; Chen CP
Endocrinology; 2005 Oct; 146(10):4179-88. PubMed ID: 15961557
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue.
Maeda T; Lloyd RV
Lab Invest; 1993 Apr; 68(4):472-80. PubMed ID: 8479155
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
Jakowlew SB; Mathias A; Chung P; Moody TW
Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
[TBL] [Abstract][Full Text] [Related]
16. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta regulation of estradiol-induced prolactinomas.
Hentges S; Sarkar DK
Front Neuroendocrinol; 2001 Oct; 22(4):340-63. PubMed ID: 11587556
[TBL] [Abstract][Full Text] [Related]
18. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen.
Burns G; Sarkar DK
Endocrinology; 1993 Sep; 133(3):1444-9. PubMed ID: 8365375
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
